The Pre-Peel Consultation & Skin Assessment

The pre-peel consultation is where most peel outcomes are actually decided. Before any acid touches skin, the consult establishes the indication, scores the Fitzpatrick type and PIH risk that set the safe depth ceiling, screens contraindications, plans priming, and lands realistic expectations and informed consent. A disciplined consultation is the single most effective complication-prevention step you have — far more than anything you do during application.

Focused history

Take a targeted history aimed at peel safety, not a generic skin review:

Primary concern and goal — acne, PIH, melasma, tone, texture, photoaging — and what "success" means to the patient.
Prior procedures and topicals — previous peels and their reactions, retinoid use, active acids, recent waxing/threading/lasers.
Isotretinoin — recent or current systemic isotretinoin is a recognised precaution for medium/deep peeling and abrasive procedures because of impaired re-epithelialization; defer and document.
Herpes simplex history — periorial/facial HSV warrants antiviral prophylaxis to prevent post-peel reactivation, especially for medium-depth peels.
Scarring tendency — keloid or hypertrophic-scar history materially changes risk.
Pigmentation history — prior PIH, melasma triggers, hormonal factors, and how the skin has tanned/marked before.
Photoexposure and sun behaviour — recent or anticipated sun exposure raises risk and may delay treatment.

Fitzpatrick and PIH-risk assessment

Score the Fitzpatrick phototype (I–VI) explicitly — it is the backbone of risk stratification. Then estimate PIH risk as a function of phototype, the inflammatory load of the planned peel, and the patient's pigmentary history. The higher the phototype and the more reactive the history, the lower the depth ceiling and the more conservative the agent.

Fitzpatrick phototypes I–VI — highlighted: IV, V, VI

For Indian and other predominantly Fitzpatrick IV–VI populations, this assessment usually points to superficial-to-controlled-medium depth, metabolic or mandelic-first agents, and priming — not because deeper peels can't help, but because the risk-adjusted return favours restraint.

Contraindications and precautions

Category	Examples
Absolute / defer	Active local infection (bacterial, herpetic, warts in the field); open wounds/dermatitis in the treatment area
Recent isotretinoin	Precaution for medium/deep peels — impaired healing; defer per current guidance and document
Pregnancy / lactation	Avoid retinoid and salicylate-heavy peels; counsel and defer elective procedures
Unrealistic expectations	A behavioural contraindication — proceed only after expectations are aligned
Poor photoprotection / imminent sun	Defer until adherence and exposure are controlled
Keloid / hypertrophic tendency	Heightened caution; favour superficial depth

The consult workflow

Pre-peel consult, step by step

History
Capture indication, prior procedures, isotretinoin, HSV, scarring tendency, pigment history and sun behaviour.
Examine & phototype
Assess the skin, baseline pigment and barrier; score Fitzpatrick type and estimate PIH risk.
Screen contraindications
Rule out active infection, recent isotretinoin, pregnancy concerns and behavioural red flags; arrange HSV prophylaxis if indicated.
Select depth & agent
Match agent, strength and target depth to the concern and the safe ceiling the phototype allows — start conservative.
Prime
Pre-condition reactive or darker skin (e.g. with a retinoid and/or tyrosinase inhibitor over a few weeks) to standardise penetration and lower PIH risk.
Patch test where appropriate
Consider a test spot in highly reactive skin or with a new agent before full-face application.
Set expectations & consent
Explain the planned series, realistic outcomes, downtime, that shedding is not a measure of efficacy, and the risks; obtain and document informed consent.

Priming

Priming pre-conditions the skin in the weeks before peeling — typically a retinoid to normalise turnover and, in pigment-prone skin, a tyrosinase inhibitor to quiet melanocytes. It standardises penetration (so the same protocol lands at the same depth) and lowers PIH risk, which is why it is close to mandatory before peeling Fitzpatrick IV–VI skin. Priming also flags intolerance early, before a full peel.

Expectation-setting is a clinical step, not a courtesy. Make four things explicit before the first peel: this is a series, not a single fix; results vary by phototype, indication and protocol; shedding/frost is not a measure of efficacy; and downtime and risks (including PIH and the need for strict photoprotection) are real. Document informed consent covering the planned protocol, alternatives, expected course and complications. A patient who understands the plan is both safer and more satisfied — and a misaligned expectation is itself a reason to defer.

Key takeaway

The consult sets the ceiling for everything that follows: history surfaces the contraindications, phototype and PIH risk set the safe depth, priming makes penetration predictable, and consent aligns expectations. Do this well and the peel itself becomes the easy part.

Frequently asked questions

What are the main contraindications to a chemical peel?

Active local infection (including herpes simplex in the treatment area), open wounds or dermatitis in the field, recent systemic isotretinoin for medium/deep peels, pregnancy or lactation for retinoid- and salicylate-heavy peels, a keloid tendency, poor photoprotection, and unrealistic expectations. Several are reasons to defer rather than permanent bars.

How does Fitzpatrick type change the consultation?

Phototype sets the PIH-risk ceiling. Higher phototypes (IV–VI) push you toward superficial-to-controlled-medium depth, gentler or mandelic-first agents, mandatory priming and strict photoprotection, because the cost of overshooting depth is post-inflammatory hyperpigmentation.

Why is priming important before a peel?

Priming standardises how deeply the peel penetrates, so the same protocol lands at the same depth, and it lowers complication risk — especially post-inflammatory hyperpigmentation in darker skin. It also reveals intolerance to actives before a full peel is performed.